A robust xenotransplantation model for acute myeloid leukemia
Authors:
- 23 July 2009
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 23 (11) , 2109-2117
Abstract
Xenotransplantation of human acute myeloid leukemia (AML) in immunocompromised animals has been critical for defining leukemic stem cells. However, existing immunodeficient strains of mice have short life spans and low levels of AML cell engraftment, hindering long-term evaluation of primary human AML biology. A recent study suggested that NOD/LtSz-scid IL2Rγc null (NSG) mice have enhanced AML cell engraftment, but this relied on technically challenging neonatal injections. Here, we performed extensive analysis of AML engraftment in adult NSG mice using tail vein injection. Of the 35 AML samples analyzed, 66% showed bone marrow engraftment over 0.1%. Further, 37% showed high levels of engraftment (>10%), with some as high as 95%. A 2–44-fold expansion of AML cells was often seen. Secondary and tertiary recipients showed consistent engraftment, with most showing further AML cell expansion. Engraftment did not correlate with French–American–British subtype or cytogenetic abnormalities. However, samples with FLT3 mutations showed a higher probability of engraftment than FLT3 wild type. Importantly, animals developed organomegaly and a wasting illness consistent with advanced leukemia. We conclude that the NSG xenotransplantation model is a robust model for human AML cell engraftment, which will allow better characterization of AML biology and testing of new therapies.Keywords
This publication has 19 references indexed in Scilit:
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Human acute leukemia cells injected in NOD/LtSz‐scid/IL‐2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid‐related strainsInternational Journal of Cancer, 2008
- Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cellsBlood, 2008
- Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal regionNature Biotechnology, 2007
- Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibresBritish Journal of Haematology, 2007
- Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull miceBlood, 2005
- Detection of FLT3 Internal Tandem Duplication and D835 Mutations by a Multiplex Polymerase Chain Reaction and Capillary Electrophoresis AssayThe Journal of Molecular Diagnostics, 2003
- Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factorsLeukemia, 2003
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997